John D Fisher

Comparison of defibrillator therapy and other therapeutic modalities for sustained ventricular tachycardia or ventricular fibrillation associated with coronary artery disease.

J. Fisher, S. Furman, K. Ferrick, 1994, The American journal of cardiology.

Susceptibility to atrial fibrillation and ventricular tachyarrhythmia in the Wolff-Parkinson-White syndrome: role of the accessory pathway.

J. Fisher, R. Brodman, S. Kim, 1986, American heart journal.

Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.

J. Fisher, S. Kim, L. Waspe, 1986, The American journal of cardiology.

Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias.

J. Fisher, S. Kim, A. Mercando, 1989, Journal of the American College of Cardiology.